Trial Profile
Effect of renal impairment on apixaban
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Sep 2015
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Renal impairment
- Focus Pharmacokinetics
- 15 Sep 2015 New trial record
- 11 Sep 2015 Results published in the Journal of Clinical Pharmacology.